Literature DB >> 320990

The bronchodilator effect of NAB 365.

P L Kamburoff, F J Prime, O P Schmidt.   

Abstract

1. Dose response relationships for salbutamol and a new bronchodilator drug NAB 365 have been obtained in patients with reversible airways obstruction. These show that the latter is about one hundred times more potent than the former. 2. NAB 365 has a very long half-life. The implications of this are discussed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 320990      PMCID： PMC1428977          DOI： 10.1111/j.1365-2125.1977.tb00669.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  4 in total

1.  [Structure activity relationship in a series of new amino-halogen substituted phenyl-aminoethanols].

Authors:  G Engelhardt
Journal:  Arzneimittelforschung       Date:  1972-05

2.  [Pulmonary function tests using the broncholytic agent NAB 365].

Authors:  D Nolte; F Laumen
Journal:  Med Monatsschr       Date:  1972-07

3.  [The clinical pharmacology of a new specific adrenergic beta bronchodilator].

Authors:  P C Curti
Journal:  Int J Clin Pharmacol       Date:  1974-06

4.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

Authors:  A B DUBOIS; S Y BOTELHO; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808
  4 in total
  4 in total

1.  Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.

Authors:  A Baronti; A Griceo; C Vibelli
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

2.  Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo.

Authors:  T L Whitsett; C V Manion; M F Wilson
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

3.  Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.

Authors:  M Tschan; A Perruchoud; H Herzog
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

4.  A trial of clenbuterol in bronchial asthma.

Authors:  G Anderson; E Wilkins
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.